{"id":3471,"date":"2022-06-15T14:49:31","date_gmt":"2022-06-15T12:49:31","guid":{"rendered":"https:\/\/www.akern.com\/?p=3471"},"modified":"2022-08-10T16:04:55","modified_gmt":"2022-08-10T14:04:55","slug":"akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group","status":"publish","type":"post","link":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/","title":{"rendered":"AKERN\u00ae becomes part of the PHARMANUTRA group"},"content":{"rendered":"<p><strong>Pharmanutra S.p.A.<\/strong>, a company listed on the STAR segment of the Italian Stock Exchange, takes over the ownership of <strong>Akern<sup>\u00ae<\/sup> s.r.l.<\/strong>. <strong>PharmaNutra<\/strong> group (<a href=\"https:\/\/www.pharmanutra.it\/en\/\">www.pharmanutra.it\/en<\/a>) is one of the most regarded Italian companies in the pharmaceutical and nutraceutical industry, thanks to the constant innovation of products and patented technologies developed for the food supplement market and in the sports field.<br \/>\nThese are the words of <em>Andrea Lacorte<\/em>, President of the PharmaNutra Group: &#8220;T<em>he acquisition of Akern<sup>\u00ae<\/sup> represents a turning point for both companies [&#8230;] PharmaNutra will substantially strengthen its know-how, benefiting from the experience of an Italian company, a reference brand for bioimpedance analysis for over 40 years, and at the same time it will guarantee Akern<sup>\u00ae<\/sup> consolidation on the national and foreign market thanks to the Group&#8217;s network of distributors. A synergy aimed at increasing exponentially competitiveness, therefore guaranteeing enormous growth opportunities with the creation of value for the shareholders&#8221;.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmanutra S.p.A., a company listed on the STAR segment of the Italian Stock Exchange, takes over the ownership of Akern\u00ae s.r.l.. PharmaNutra group (www.pharmanutra.it\/en) is one of the most regarded Italian companies in the pharmaceutical and nutraceutical industry, thanks to the constant innovation of products and patented technologies developed for the food supplement market and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3467,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-3471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsroom"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AKERN\u00ae becomes part of the PHARMANUTRA group - Akern<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AKERN\u00ae becomes part of the PHARMANUTRA group - Akern\" \/>\n<meta property=\"og:description\" content=\"Pharmanutra S.p.A., a company listed on the STAR segment of the Italian Stock Exchange, takes over the ownership of Akern\u00ae s.r.l.. PharmaNutra group (www.pharmanutra.it\/en) is one of the most regarded Italian companies in the pharmaceutical and nutraceutical industry, thanks to the constant innovation of products and patented technologies developed for the food supplement market and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/\" \/>\n<meta property=\"og:site_name\" content=\"Akern\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-15T12:49:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-10T14:04:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"862\" \/>\n\t<meta property=\"og:image:height\" content=\"646\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"zaki\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"zaki\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/\",\"url\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/\",\"name\":\"AKERN\u00ae becomes part of the PHARMANUTRA group - Akern\",\"isPartOf\":{\"@id\":\"https:\/\/www.akern.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg\",\"datePublished\":\"2022-06-15T12:49:31+00:00\",\"dateModified\":\"2022-08-10T14:04:55+00:00\",\"author\":{\"@id\":\"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#primaryimage\",\"url\":\"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg\",\"contentUrl\":\"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg\",\"width\":862,\"height\":646},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.akern.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AKERN\u00ae becomes part of the PHARMANUTRA group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.akern.com\/en\/#website\",\"url\":\"https:\/\/www.akern.com\/en\/\",\"name\":\"Akern\",\"description\":\"Science in body composition\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.akern.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082\",\"name\":\"zaki\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.akern.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g\",\"caption\":\"zaki\"},\"sameAs\":[\"https:\/\/www.akern.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AKERN\u00ae becomes part of the PHARMANUTRA group - Akern","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/","og_locale":"en_US","og_type":"article","og_title":"AKERN\u00ae becomes part of the PHARMANUTRA group - Akern","og_description":"Pharmanutra S.p.A., a company listed on the STAR segment of the Italian Stock Exchange, takes over the ownership of Akern\u00ae s.r.l.. PharmaNutra group (www.pharmanutra.it\/en) is one of the most regarded Italian companies in the pharmaceutical and nutraceutical industry, thanks to the constant innovation of products and patented technologies developed for the food supplement market and [&hellip;]","og_url":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/","og_site_name":"Akern","article_published_time":"2022-06-15T12:49:31+00:00","article_modified_time":"2022-08-10T14:04:55+00:00","og_image":[{"width":862,"height":646,"url":"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg","type":"image\/jpeg"}],"author":"zaki","twitter_card":"summary_large_image","twitter_misc":{"Written by":"zaki","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/","url":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/","name":"AKERN\u00ae becomes part of the PHARMANUTRA group - Akern","isPartOf":{"@id":"https:\/\/www.akern.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#primaryimage"},"image":{"@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#primaryimage"},"thumbnailUrl":"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg","datePublished":"2022-06-15T12:49:31+00:00","dateModified":"2022-08-10T14:04:55+00:00","author":{"@id":"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082"},"breadcrumb":{"@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#primaryimage","url":"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg","contentUrl":"https:\/\/www.akern.com\/wp-content\/uploads\/2022\/08\/pharmanutra.jpg","width":862,"height":646},{"@type":"BreadcrumbList","@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-s-r-l-becomes-part-of-the-pharmanutra-s-p-a-group\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.akern.com\/en\/"},{"@type":"ListItem","position":2,"name":"AKERN\u00ae becomes part of the PHARMANUTRA group"}]},{"@type":"WebSite","@id":"https:\/\/www.akern.com\/en\/#website","url":"https:\/\/www.akern.com\/en\/","name":"Akern","description":"Science in body composition","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.akern.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082","name":"zaki","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.akern.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g","caption":"zaki"},"sameAs":["https:\/\/www.akern.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts\/3471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/comments?post=3471"}],"version-history":[{"count":3,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts\/3471\/revisions"}],"predecessor-version":[{"id":3474,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts\/3471\/revisions\/3474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/media\/3467"}],"wp:attachment":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/media?parent=3471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/categories?post=3471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/tags?post=3471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}